Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms
- PMID: 38783955
- PMCID: PMC11112518
- DOI: 10.3389/fphar.2024.1377592
Treatment of colorectal cancer by traditional Chinese medicine: prevention and treatment mechanisms
Abstract
Colorectal cancer (CRC) is a significant global health burden, with high morbidity and mortality rates. It is often diagnosed at middle to advanced stage, affecting approximately 35% of patients at the time of diagnosis. Currently, chemotherapy has been used to improve patient prognosis and increase overall survival. However, chemotherapy can also have cytotoxic effects and lead to adverse reactions, such as inhibiting bone marrow hematopoiesis, causing digestive dysfunction, hand-foot syndrome, and even life-threatening conditions. In response to these adverse effects, researchers have proposed using Traditional Chinese Medicine (TCM) as an option to treat cancer. TCM research focuses on prescriptions, herbs, and components, which form essential components of the current research in Chinese medicine. The study and implementation of TCM prescriptions and herbs demonstrate its distinctive holistic approach to therapy, characterized by applying multi-component and multi-target treatment. TMC components have advantages in developing new drugs as they consist of single ingredients, require smaller medication dosages, have a precise measure of pharmacodynamic effects, and have a clear mechanism of action compared to TCM prescriptions and herbs. However, further research is still needed to determine whether TMC components can fully substitute the therapeutic efficacy of TCM prescriptions. This paper presents a comprehensive analysis of the research advancements made in TCM prescriptions, herbs, and components. The findings of this study can serve as a theoretical basis for researchers who are interested in exploring the potential of TCM for the treatment of colorectal cancer.
Keywords: colorectal cancer; components; herbs; prescriptions; traditional Chinese medicine.
Copyright © 2024 Sun, Wei, Wang, Hou and Su.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
Similar articles
-
[Precise application of Traditional Chinese Medicine in minimally-invasive techniques].Zhongguo Gu Shang. 2018 Jun 25;31(6):493-496. doi: 10.3969/j.issn.1003-0034.2018.06.001. Zhongguo Gu Shang. 2018. PMID: 29945400 Chinese.
-
Prescriptions of traditional Chinese medicine are specific to cancer types and adjustable to temperature changes.PLoS One. 2012;7(2):e31648. doi: 10.1371/journal.pone.0031648. Epub 2012 Feb 16. PLoS One. 2012. PMID: 22359613 Free PMC article.
-
Research progress in the treatment of slow transit constipation by traditional Chinese medicine.J Ethnopharmacol. 2022 May 23;290:115075. doi: 10.1016/j.jep.2022.115075. Epub 2022 Feb 5. J Ethnopharmacol. 2022. PMID: 35134487 Review.
-
[Application and progress of data mining in study of compatibility law of traditional Chinese medicine].Zhongguo Zhong Yao Za Zhi. 2021 Oct;46(20):5233-5239. doi: 10.19540/j.cnki.cjcmm.20210303.501. Zhongguo Zhong Yao Za Zhi. 2021. PMID: 34738424 Chinese.
-
Can highly cited herbs in ancient Traditional Chinese medicine formulas and modern publications predict therapeutic targets for diabetes mellitus?J Ethnopharmacol. 2018 Mar 1;213:101-110. doi: 10.1016/j.jep.2017.10.032. Epub 2017 Nov 2. J Ethnopharmacol. 2018. PMID: 29102765 Review.
Cited by
-
The Wnt/β-catenin signaling pathway in colorectal cancer: mechanism and intervention of traditional Chinese medicine and chemical compound.Front Pharmacol. 2025 Apr 10;16:1560714. doi: 10.3389/fphar.2025.1560714. eCollection 2025. Front Pharmacol. 2025. PMID: 40308773 Free PMC article. Review.
-
Network Pharmacology and Bioinformatics Study of Six Medicinal Food Homologous Plants Against Colorectal Cancer.Int J Mol Sci. 2025 Jan 23;26(3):930. doi: 10.3390/ijms26030930. Int J Mol Sci. 2025. PMID: 39940699 Free PMC article.
-
The mechanism of Shancigu and its monomer in the development of colorectal cancer based on network pharmacology.Sci Rep. 2025 Jul 2;15(1):23186. doi: 10.1038/s41598-025-04795-7. Sci Rep. 2025. PMID: 40603959 Free PMC article.
-
Progress of traditional Chinese medicine in the prevention and treatment of colorectal cancer.World J Gastrointest Oncol. 2025 Jun 15;17(6):105690. doi: 10.4251/wjgo.v17.i6.105690. World J Gastrointest Oncol. 2025. PMID: 40547140 Free PMC article. Review.
-
Formation of self-assembly aggregates in traditional Chinese medicine decoctions and their application in cancer treatments.RSC Adv. 2025 Feb 18;15(7):5476-5506. doi: 10.1039/d4ra07212j. eCollection 2025 Feb 13. RSC Adv. 2025. PMID: 39967882 Free PMC article. Review.
References
-
- Alorda-Clara M., Torrens-Mas M., Morla-Barcelo P. M., Roca P., Sastre-Serra J., Pons D. G. (2022). High Concentrations of Genistein Decrease Cell Viability Depending on Oxidative Stress and Inflammation in Colon Cancer Cell Lines. Int J Mol Sci. 23 (14), 7526. 10.3390/ijms23147526 - DOI - PMC - PubMed
-
- Balmus I. M., Ciobica A., Trifan A., Stanciu C. (2016). The implications of oxidative stress and antioxidant therapies in Inflammatory Bowel Disease: clinical aspects and animal models. Saudi J. gastroenterology official J. Saudi Gastroenterology Assoc. 22 (1), 3–17. 10.4103/1319-3767.173753 - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources